Creative Biolabs Expands Research Offerings for Complement Assays and Microfluidics

What Happened

Creative Biolabs has updated its research portfolio to address common technical hurdles in complement therapeutics and microfluidic workflows. The company is providing standardized tools aimed at reducing data variability and improving experimental control.

For complement biology, the firm introduced a functional test kit for assessing the classical pathway through red blood cell lysis. This is paired with a profiling service designed to help researchers measure the potency of inhibitors and examine their specific biological effects.

In the field of microfluidics, the company released a specialized flow-focusing chip. This hardware is intended to assist in the consistent generation of droplets for single-cell encapsulation and compartmentalized screening projects.

The Core Points

New functional test kits for classical complement pathway assessment
Hemolysis inhibition profiling service for inhibitor potency verification
Introduction of PDMS-based flow-focusing chips for droplet generation
Tools designed to improve reproducibility in single-cell encapsulation
Support for cross-species complement studies, including human and rodent models

Context in 60 Seconds

Translational research increasingly relies on precise, multi-dimensional data to validate therapeutic candidates. As drug development shifts toward more complex biological pathways, the demand for reliable, standardized assay systems has grown to ensure reproducibility across laboratories.

Simultaneously, microfluidic technology continues to evolve as a standard for high-throughput screening and single-cell analysis. Providing stable, off-the-shelf tools for these workflows helps researchers minimize the technical overhead associated with building custom experimental setups, ultimately accelerating the pace of early-stage discovery.

Bottom Line

By offering standardized kits for complement analysis and microfluidic hardware, Creative Biolabs is helping researchers achieve more consistent results in complex biological and cellular workflows.

Loading briefing details...